Patent: 7,371,531
✉ Email this page to a colleague
Summary for Patent: 7,371,531
Title: | Use of an extraction control in a method of extracting nucleic acids |
Abstract: | The present invention relates to a method of ensuring the effectiveness of the extraction workup from a biological sample of nucleic acid. The inventive method is able to distinguish between possible defects in the extraction of nucleic acid from a sample and possible defects in a subsequent amplification step. The present invention also relates to a packaged array for extracting nucleic acid from a biological sample. |
Inventor(s): | Hellyer; Tobin (Westminster, MD), Fort; Thomas (Hanover, PA), McMillian; Ray A. (Timonium, MD) |
Assignee: | Becton, Dickinson and Company (Franklin Lakes, NJ) |
Application Number: | 11/114,952 |
Patent Claims: | see list of patent claims |
Details for Patent 7,371,531
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2024-04-23 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2024-04-23 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2024-04-23 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |